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Abstract 
Aims and objectives. To take a systematic approach to reviewing the scientific literature 
examining the timeliness of vaccination in preterm infants and to identify any factors associated 
with timeliness. 
Background. Preterm infants are vulnerable to infection and guidance advocates they are 
vaccinated in accordance with their full term peers. Vaccination is well tolerated and protective 
immune responses are observed, yet some early enquiries suggest that preterm infants 
experience unwarranted delays. The recent surge in pertussis cases and the increase in 
vaccinations administered make this a topic requiring further exploration. 
Design. An integrative review of the empirical literature. 
Methods. Studies were identified following a search of Medline, Academic Search Premier, 
Cochrane Database of Systematic Reviews and the Cumulative Index to Nursing and Allied 
Health Literature. The review methods used were influenced by a narrative synthesis approach. 
The retrieval of papers adhered to recognised reporting standards. 
Results. Fourteen studies were identified, which indicated that infants with the lowest 
gestational ages and birth weights experience the greatest delays. Vaccination timeliness is 
influenced by hospitalisation, and increased post-discharge follow-up. There was a lack of 
consensus to indicate that parental socio-economic status and level of education were indicators 
for a delay. The studies propose that many delays are unjustified and not according to genuine 
contraindications. 
Conclusion. This review indicates that preterm infants are not vaccinated in a timely manner. 
Those involved in vaccinating preterm infants must be informed of the genuine 
contraindications to avoid unnecessary delays putting preterm infants at an increased risk of 
infection. 
Relevance to clinical practice. Care providers should acknowledge the risk of a delay in 
preterm infants and actively promote vaccination in this population. Regular training should 
help to negate the occurrence of inappropriate delays and careful discharge planning is needed 
to ensure that preterm infants are vaccinated on time. 
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What does this paper contribute to the wider global clinical community? 
 
•  Preterm infants experience delays in receiving their vaccinations but the delays are 
greater in those infants with the lowest gestational ages and the lowest birth weights. 
Vaccination timeliness is also associated with hospitalisation, and increased post-
discharge follow-up. The influence of parental socioeconomic status on a delay 
requires further investigation. 
• It is suggested that delays in vaccinating preterm infants are frequently unfounded 
rather than being in accordance with genuine contraindications. Strategies to address 
this issue may include increased follow up and better discharge planning and targeted 
education and information so that decisions about vaccinating preterm infants are 
made based on evidence and published guidance. 
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INTRODUCTION 
Vaccination is a fundamental public health activity, which globally is estimated to prevent 
between two and three million deaths each year (WHO, 2016a). Vaccination programmes are 
primarily aimed at infants and children because the burden of infectious disease in this 
population is vast with approximately 17,000 children from around the world under the age of 
five dying on a daily basis, often from infections which are avoidable through vaccination 
(UNICEF, 2016). Preterm infants are described as those born before 37 weeks gestation (WHO, 
2015) and when compared to their full term counterparts, the risk of infection in this population 
increases nine fold (Sinha et al., 2012); furthermore and also in comparison to full term infants, 
preterm infants face an increased risk of diseases which are vaccine preventable (Bonhoeffer 
et al., 2006), emphasising the importance of vaccination. Data regarding preterm birth 
demonstrate a rate of about 8% in the UK (Royal College of Obstetricians and Gynaecologists, 
2014), whilst in the US this is much greater at 11% (Centers for Disease Control and Prevention, 
2014). However, the wider burden of preterm birth was less well known until the WHO and 
member states collaborated to publish an analysis of worldwide preterm birth estimates, and 
the findings of this analysis report a rate of 11.1% and indicate that there is a global increasing 
trend in preterm births (Blencowe et al., 2012). Nurses play a vital role in advising on and 
administering vaccinations, therefore given the increasing rate of preterm birth and the 
importance of vaccination in this vulnerable population, vaccination practices in preterm 
infants is a topic worthy of further critical examination. This paper presents a review of the 
literature investigating the timeliness of vaccination in preterm infants. 
Background 
Infants born prematurely are able to attain immunological responses to vaccination which are 
considered to be protective. Observed responses to the diphtheria, tetanus, pertussis, polio and 
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Hib components of the pentavalent vaccine and responses to the pneumococcal conjugate 
vaccine, both commonly administered in the first year of life, indicate that immunological 
protection is achieved; however for infants born prematurely, this level of protection does 
positively correlate with gestational age (Saari et al., 2003; Bonhoeffer et al., 2006; D’Angio, 
2007). Similar findings are also reported for the meningococcal type C vaccine (D’Angio, 2007) 
and oral rotavirus vaccine (Omeneca et al., 2012), also both given in infancy. Preterm infants 
are capable of tolerating the administration of vaccines and Bonhoeffer et al. (2006) cite similar 
rates of vaccination associated side effects in preterm infants to those seen in their full term 
counterparts. However, some studies report an increase in respiratory and cardiac symptoms in 
preterm infants post vaccination, although this increase is associated with previous history of 
the symptoms (Klein et al., 2008; Hacking et al., 2010). The symptoms observed post 
vaccination in preterm infants are predominantly self-limiting and a period of observation may 
be appropriate (Schulzke et al., 2005; Faldella et al., 2007). However, when the increased 
infection risk associated with prematurity is considered, such side effects are no justification 
for withholding vaccination (Esposito et al., 2009).  
Globally, policy advocates that preterm infants are vaccinated in accordance with their full 
term peers (The American Academy of Pediatrics, 2015; Australian Government, 2016; 
Salisbury and Ramsay, 2014). Nonetheless, despite well-established vaccination programmes 
resulting in respectable uptake rates, some early enquiries have suggested that preterm infants 
are not being vaccinated in a timely manner (Vohr and Oh, 1986; Wariyar et al., 1989). Given 
that preterm infants are particularly vulnerable to infection, the changes made to the 
vaccination schedule globally in response to the development of new vaccines and 
epidemiological data, and the recent surge in pertussis cases in infants which saw a 15% 
increase in the US between the years of 2013 and 2014 (CDC, 2015), this is an issue worthy of 
further contemporary investigation. Several studies have been undertaken to explore this issue, 
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and this review presents a synthesis of their findings which is guided by the work of Popay et 
al. (2006).  
The review 
AIMS 
The aim of this integrative review was to undertake a search of the scientific literature guided 
by a narrative synthesis approach (Popay et al., 2006) investigating the timeliness of 
vaccination in preterm infants. More specifically, the review aims to answer the questions: (1) 
is there a delay in the vaccination of preterm infants?, and (2) what are the factors associated 
with vaccination timeliness in preterm infants? Owing to a substantial level of heterogeneity 
across the selected studies regarding methods and outcomes, a more traditional meta-analysis 
approach associated with systematic reviews was not possible. This review presents a narrative 
synthesis of the literature referring to the guidance by Popay et al. (2006) which consists of 
four elements; developing the theory, preliminary synthesis, exploring relationships and 
assessing the robustness of the synthesis. It is emphasised that these four elements are not 
undertaken sequentially and reviewers should move between them in an iterative manner 
(Popay et al., 2006). 
METHODS 
To identify relevant studies, the electronic databases Medline, Academic Search Premier, 
Cochrane Database of Systematic Reviews and the Cumulative Index to Nursing and Allied 
Health Literature were systematically searched using pertinent terms including ‘vaccination’, 
‘preterm’, ‘delay’ and associated synonyms. The titles and abstracts of the identified sources 
were reviewed and excluded if they were not primary studies with a quantitative design, did 
not feature preterm infants, were not peer reviewed or did not recognise published guidance on 
the recommendations for the vaccination of preterm infants. Additional inclusion criteria were 
that the studies needed to be in English and focus on routine scheduled vaccines. To facilitate 
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a comprehensive review, there were no limitations on year or place of publication, this would 
also identify any trends over time. The sources which met these criteria were subjected to 
further review by accessing the full text versions.  
Search outcome 
For the retrieval of the relevant studies, the Preferred Reporting System for Systematic Reviews 
and Meta-analyses (PRISMA) (Moher et al. 2009) was adhered to (Figure. 1). Following the 
removal of duplicates (n=128), the initial search identified 761 sources. After screening the 
titles and abstracts, a further 713 sources were excluded for not meeting the inclusion criteria 
leaving 48 to be assessed by full text. At this stage, an additional 34 sources were excluded for 
reasons including not being a primary source, not available in English and not being focused 
on preterm infants. This left 14 studies for inclusion in the review. No additional relevant 
studies were identified via reviewing the reference lists of identified studies or citation 
searching. The entire search and identification of relevant studies was undertaken by one author 
(HS). In accordance with the inclusion criteria, the identified studies adopted quantitative 
designs and were undertaken in the United Kingdom (UK), United States (US), Australia, Italy, 
France, Canada, Switzerland and The Netherlands between the years of 1988 and 2014. A 
summary of the studies included in the review is presented in Table 1. 
Quality appraisal 
The quality appraisal of the studies was guided by the stage termed by Popay et al. (2006) as 
assessing the robustness of the synthesis. An element of this included best evidence synthesis, 
described as an assessment of the studies’ methodological quality. Popay et al. (2006) recognise 
the variety of methods used by studies in a review and therefore rather than recommend a single 
approach to appraisal, a systematic approach in assessing study quality is advocated. 
Consequently, undertaking the quality assessment in this review, necessitated the use of two 
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approaches; initially the appraisal framework developed by Coughlan et al. (2007) for 
quantitative studies was used, but to supplement this the work of Mongan (2013) was 
incorporated (Table 2). Mongan (2013) specifically questions the quality of secondary data 
sources, which was deemed entirely appropriate given that nine out of the fourteen studies 
included in the review used secondary data. Whilst the quality appraisal highlighted differences 
in both the methods used and the outcomes observed across the studies, they were all 
considered to be of adequate methodological quality to be included in the review, therefore 
none were excluded at this stage. 
Data abstraction and synthesis 
The quality appraisal stage as previously described required the identification of key 
methodological data, and this meant that the processes of quality appraisal and data extraction 
naturally overlapped. Relevant data from all included studies were captured using a template 
(Table 2) which was specifically developed for the review, and included features defined by 
Coughlan et al. (2007) and Mongan (2013). In addition to the information captured in Table 1, 
the template facilitated the extraction of data concerning the methods used within the studies. 
Popay et al. (2006) describe the element of preliminary synthesis as an initial description of the 
included studies where patterns across them begin to emerge; an element which was facilitated 
by this data abstraction. As the studies were analysed using a narrative synthesis approach, this 
stage of the review was significantly guided by the elements described by Popay et al. (2006) 
as preliminary synthesis and exploring relationships. More specifically, the processes of 
tabulation, developing groupings and clusters, vote counting and data translation facilitated the 
analysis.  
RESULTS 
Description of included studies 
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The process of tabulation and the development of groupings and clusters were activities in the 
synthesis which identified similarities and differences between the concepts defined in each of 
the studies. Given that the studies were all addressing the timeliness of vaccination in preterm 
infants, the concepts explored at this stage were vaccination, preterm infants and timeliness. 
The vaccinations studied depended on the schedule in the countries where the studies were 
undertaken, but they all included the combined diphtheria, tetanus and pertussis vaccine. All 
but four studies included the Haemophilus influenza type b vaccine (Langkamp et al., 2001; 
Roper & Day, 1988; Ruiz et al., 1991; Woestenberg et al., 2014) and except for three studies 
(Roper & Day, 1988; Ruiz et a., 1991; Slack & Thwaites, 2000), the remainder included polio 
vaccination in their analyses. Other vaccines investigated across the studies included hepatitis 
B (n=3) (Batra et al., 2009; Crawford et al., 2009; Tozzi et al., 2014), pneumococcal conjugate 
vaccine (n=4) (Crawford et al., 2009; Denziot et al., 2011; Tozzi et al., 2014; Wilson et al., 
2012), meningococcus type C vaccine (n=3) (Crawford et al., 2009; Slack & Thwaites, 2000; 
Toxxi et al., 2014), measles, mumps and rubella combined vaccine (n=6) (Crawford et al., 2009; 
Davis et al., 1999; Langkamp et al., 2001; Magoon et al., 1995; Tillmann et al., 2001; Tozzi et 
al., 2014) and varicella vaccine (n=2) (Crawford et al., 2009; Tozzi et al., 2014). The definition 
of prematurity also varied between the included studies, but most of them defined full term as 
≥37 weeks gestational age. Some studies used a combination of gestational age and birth weight 
to identify infants (Davis et al., 1999; Roper & Day, 1988; Tillmann et al., 2001; Woestenberg 
et al., 2014), whereas others used either gestational age only (Crawford et al., 2009; Denziot et 
al., 2011; McKechnie & Finlay, 1999, Slack & Thwaites, 2000; Tozzi et al., 2014 Wilson et 
al., 2012) or birth weight (Batra et al., 2009; Langkamp et al., 2001; Magoon et al., 1995). One 
study classified infants by risk, where one of the criteria for being high risk was a birth weight 
of less than or equal to 1500g Ruiz et al., 1991).  Of those using birthweight alone, in the 
majority of studies, normal birth weight was defined as ≥2500g. Eight of the studies used data 
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from one or more neonatal units (Crawford et al., 2009; Denziot et al., 2011; Magoon et al., 
1995; McKechnie & Finlay, 1999; Roper & Day, 1988; Ruiz et al., 1991; Slack & Thwaites, 
2000; Tillmann et al., 2001) three used regional data (Batra et al., 2009; Davis et al., 1999; 
Wilson et al., 2012), and three used national data (Langkamp et al., 2001; Tozzi et al., 2014; 
Woestenberg et al., 2014). The way in which timeliness of vaccination was interpreted between 
the studies also varied. Some explored age specific vaccination status, expressing the findings 
in terms of the infants being up to date at a defined age, whereas others compared uptake rates 
between full term and preterm infants. Some also measured the extent of any delays, reporting 
the differences between full term and preterm infants in mean days. All of the studies 
acknowledged the clinical importance and recommendations of vaccinating preterm infants 
without delay and in accordance with guidance. This review presents a narrative synthesis of 
data concerning 149,754 preterm or low birth weight infants and 1,910,388 full term or normal 
birthweight infants from across the included studies. 
Main findings 
The preliminary synthesis element of the guidance by Popay et al. (2006) suggests the 
processes of vote counting and data translation in the identification of findings. Vote counting 
is described as a method of calculating the frequency of different results across the studies 
(Popay et al., 2006) and although this review does not attempt to synthesise the results of the 
studies using statistical methods, an element of this was adopted by grouping similar findings. 
This activity naturally drew on the stage described by Popay et al. (2006) as translating data (a 
process akin to thematic analysis), and the additional element of exploring relationships (Popay 
et al., 2006). As a result, the findings expressed are grouped into the themes of gestational age 
and birth weight, hospitalisation, and infants and family characteristics. 
Gestational age and birth weight 
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Two studies observed an overall delay in vaccination uptake in preterm infants, and relative to 
full term infants, preterm infants had lower up-to-date statuses (Denziot et al., 2011; Tillmann 
et al., 2001). A similar association between gestational age and lower rates of vaccination was 
reported by Wilson et al. (2012) but only in conjunction with the infant being hospitalised. This 
is in contrast to the finding that hospitalisation meant that infants with a gestational age of <28 
weeks were significantly more likely to be up-to-date at 2 months (Crawford et al., 2009). 
Magoon et al. (1995) reported a significant delay for the first vaccinations which increased as 
gestational age decreased and this trend was also observed for the second and third vaccinations 
by McKechnie and Finlay (1999).  Slack and Thwaites (2000) found that median age at first 
and third scheduled vaccinations negatively correlated to gestational age, and a higher median 
age at first vaccination in extremely preterm infants (<32 weeks) relative to full term infants 
was observed by Woestenberg et al., (2014). Of significance is the finding that as gestational 
age decreased, delays in vaccination increased and up-to-date vaccination rates were lower 
(Magoon et al., 1995; McKechnie & Finlay, 1999; Slack & Thwaites, 2000). Two of the studies 
did not find an association between gestational age and delays or up-to-date rates (Davis et al., 
1999; Tozzi et al., 2014).  
Infants with an extremely low birth weight (ELBW) consistently experienced substantial delays 
in vaccination relative to normal birth weight (NBW) infants, and these infants were also 
considerably less up-to-date compared to NBW infants (Batra et al., 2009). However, the same 
study did not find a significant difference in delays or up-to-date rates between low birth weight 
(LBW) and NBW infants. These findings are comparable with others where it is reported that 
very low birth weight (VLBW) and moderately low birth weight (MLBW) infants received 
their first and second scheduled vaccinations later than NBW infants (Langkamp et al., 2001). 
Similarly, the rate of vaccination at one year for high risk infants (which included those with a 
birth weight ≤1500g) was substantially lower than infants in the normal and low risk categories 
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(Ruiz et al., 1991). A further study found that extremely low birth weight infants had a higher 
median age at first vaccination relative to NBW infants (Woestenberg et al., 2014) and 
compared to their NBW peers, LBW infants also experienced delays in the administration of 
the first scheduled vaccines (Roper & Day, 1988; Magoon et al., 1995).These findings support 
the observation of an important negative correlation between median age at first and third 
vaccination and birth weight (Slack & Thwaites, 2000).  These studies featuring birth weight 
report findings which are consistent; low birth weight is associated with delays in vaccination 
and lower up-to-date vaccination status. Some of the studies reported that the lowest birth 
weight infants experienced the greatest delays and were less likely to be up-to-date (Magoon 
et al., 1995; Slack & Thwaites, 2000; Batra et al. 2009).  
The associations between gestational age, and birth weight and vaccination timeliness are 
important observations. Despite variability in the methods used and the quality of the studies 
involved, the frequency and consistency of their occurrence strengthens these findings. Of 
equal importance is the date range of the relevant studies with the earliest being published in 
1988 (Roper & Day) and the most recent in 2014 (Woestenberg et al.), suggesting that the 
association between prematurity, birth weight and vaccination timeliness is a long standing 
issue.  
Hospitalisation  
Several of the included studies included hospitalisation in the analyses and demonstrated how 
this may influence vaccination patterns in preterm and low birth weight infants; however, a 
lack of consensus was apparent. Although the details of the findings between studies differed, 
some of them suggested that in certain circumstances, hospitalisation promotes timely 
vaccination (Crawford et al., 2009; Davis et al., 1999; Woestenberg et al., 2014).  Alternatively, 
other findings associated hospitalisation with delays and lower up-to-date vaccination rates 
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(Wilson et al., 2012; Tozzi et al., 2014; Slack and Thwaites, 2000). The methodological quality 
of these studies was not in question, suggesting that further investigation of the impact of 
hospitalisation on vaccination timeliness is needed.  
Infant and family characteristics 
One study explored ethnicity and race in relation to vaccination statuses of low birth weight 
infants. When compared with white infants, ELBW and VLBW infants from all other 
ethnicities and races demonstrated significantly lower up-to-date vaccination levels (Batra et 
al., 2009). Magoon et al. (1995) did not find an association between delays in vaccination and 
level of parental income, but this finding is refuted by a later study where it was reported that 
VLBW infants of mothers who had completed high school were significantly more up to date 
than infants of mothers who did not (Langkamp et al., 2001). Two population based studies 
reported that a lower socio-economic status was associated with lower vaccination rates 
(Langkamp et al., 2001; Tozzi et al., 2014) although this finding is at odds with the observation 
that a lower family income was associated with greater up-to-date vaccination levels (Denziot 
et al., 2011). In spite of this latter finding, the strength of the two large population based studies 
by Langkamp et al. (2001) and Tozzi et al. (2014) signifies that this is an important finding.   
Additional findings 
Vaccination rates and timeliness in preterm infants was also considered to be influenced by the 
follow up care the infant received post discharge, where improved rates were seen in those 
children who received more than the standard number of well-child visits (Davis et al., 1999; 
Denziot et al., 2011). Some studies asked respondents directly about their practice or how they 
decided whether or not to vaccinate. Ninety-five per cent of neonatologists surveyed confirmed 
that there was a local policy in place to support timely vaccination of preterm infants, but the 
survey also revealed a lack of adherence to the policy (Crawford et al., 2009). Earlier enquiries 
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dating from the 1990s reported that family practitioners were more likely to deviate from the 
recommended schedule and that parental reasons to withhold vaccination included low 
gestational age, low birth weight and minor infections (Magoon et al., 1995). Some primary 
healthcare providers cited concerns over their own liability, based on the perceived risk of 
neurological injury as a reason to withhold vaccination in preterm infants (Ruiz et al., 1991).  
DISCUSSION 
The findings of this review reveal a strong association between a delay in vaccination and 
gestational age or birth weight. Some of the studies focussed on birthweight as the independent 
variable, where others concentrated on gestational age. With the exception of three of the 
studies (Ruiz et al., 1991; Batra et al., 2009; Langkamp et al., 2001) the remainder indicated 
an association between birth weight and gestational age. Low birth weight is not always 
suggestive of prematurity; infants may be born at term small for gestational age (Lissauer & 
Clayden, 2012). However, prematurity is a leading cause of low birth weight (WHO, 2016b), 
therefore, in their entirety, the findings of all of the studies contribute to this review.   
It is suggested that delays may not be due to true contraindications rather, that inappropriate 
worries relating to gestational age or birth weight may be the cause (Roper & Day, 1988). 
Illnesses associated with prematurity may warrant a delay although this is unlikely to extend 
beyond the date of the first vaccination  (McKechnie & Finlay, 1999) and the increased 
respiratory symptoms experienced by some preterm infants may prompt further unwarranted 
delays (Slack and Thwaites, 2000). This suggests that targeted education and information 
aimed at parents and practitioners, which focusses on the importance and effectiveness of 
vaccination, is justified. Although only a feature of one study, the biggest delays are reported 
among non-white ELBW infants (Batra et al., 2009). Greater delays are also reported among 
those infants from a lower socio-economic background (Langkamp et al., 2001; Woestenberg 
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et al., 2014). The delay seen in non-white preterm infants reflects previous investigations 
suggestive of a link between lower socio-economic status and poor access to healthcare 
services; being from a non-white ethnic background is associated with under-vaccination in 
infants irrespective of prematurity (Rainey et al., 2011).  
Hospitalisation was seen as both a facilitator and a barrier to vaccination in preterm infants. 
The increase in age appropriate vaccination reported in hospitalised infants which was found 
by Crawford et al. (2009), Davis et al. (1999) and Woestenberg et al. (2014) may be attributed 
to the monitoring these infants receive whilst inpatients, increasing their chances of being 
vaccinated on time. Conversely, hospitalisation was reported as increasing the chances of 
preterm infants experiencing a delay by Wilson et al. (2012), Tozzi et al. (2014) and Slack and 
Thwaites (2000), and this may be related to the reason for hospitalisation; an unstable health 
status or concurrent problem which presents a true contraindication to vaccination may be 
present. However, prematurity itself is not a contraindication to vaccination (Salisbury & 
Ramsey, 2013), so it is vital that legitimate contraindications are understood by health care 
providers. Again, the necessity of education is highlighted here, and it is recommended that 
practitioners regularly acquire contemporaneous information regarding vaccination in preterm 
infants, so that decisions made in practice are evidence based.  
Discharge planning is a crucial influence on vaccination uptake. There is a suggestion that 
parents want their children to ‘have a rest’ after discharge by delaying vaccination, and that 
vaccination is not prioritised in discharge care plans (Tillmann et al., 2001). In addition, the 
transfer of care for the infant from the hospital to the community setting may give rise to 
confusion over who is responsible for administering the vaccination (Woestenberg et al., 2014), 
indicating the importance of coordinated discharge planning. One of the studies noted 
improved future coverage if the vaccination schedule had been initiated on the neonatal unit 
(Denziot et al., 2011), and it could be assumed that primary health care providers are more 
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confident in prescribing and administering the vaccines knowing that the infant has already 
safely received at least one dose; equally, this may also be true of parents giving consent, who 
might be assured by the fact that this would not be the first time their child is to be vaccinated.  
An increase in vaccination uptake was noted in those infants who received more than the 
standard number of visits post-discharge (Davis et al., 1999; Denziot et al., 2011).  This finding 
was also associated with low-income; in one study, infants of families with social difficulties 
including low income, were routinely offered mother-infant welfare visits, during which 
vaccination status was addressed (Denziot et al., 2011).  In the UK, policy has standardised 
contacts with all children under the age of five regardless of prematurity, and these contacts 
are an opportunity for primary health care providers to address vaccination status (Department 
of Health, 2009). However, the identification of any overdue vaccines still relies on the parents 
having the means and motivation to take their children to be vaccinated. Domiciliary 
vaccination is recommended for those families experiencing difficulties accessing services but 
this is not a service which is offered consistently in the UK (National Institute for Health and 
Care Excellence, 2009).  
None of the studies in this review were located in low-income countries and with the exception 
of five studies (Batra et al., 2009; Davis et al., 1999; Langkamp et al., 2001; Magoon et al., 
1995; Ruiz et al., 1991) which were undertaken in the United States, the remainder were located 
in countries offering some form of universal health coverage (Rodin & de Ferranti, 2012). This 
may impact on accessing health services and vaccination uptake in general across all sections 
of the population and could therefore, have influenced the findings of these studies. 
This review has some limitations. The heterogeneity of the studies included meant that a more 
traditional meta-analysis was not possible, and whilst narrative synthesis is considered a 
legitimate method of analysis there were some elements of the synthesis which were considered 
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inappropriate, and other elements were adapted prior to use. It is possible that in this 
interpretation and adaptation of the elements suggested by Popay et al. (2006), some objectivity 
has been lost. Furthermore, the searching and identification of the studies included in the 
review was undertaken by one author and no inter-rater agreement was achieved. This may 
have compromised the inclusiveness and relevance of the studies included.    
The methodological quality assessment of the included studies highlighted some of the 
limitations associated with the use of secondary data, namely assurance around the 
completeness, quality and accuracy of the data and the potential for the data to be out-of-date. 
These are all issues which were identified in the studies included and it could be disputed that 
they may have compromised the synthesis of this review. A final limitation concerns vaccine 
hesitancy generally. This review has focused on vaccination timeliness and associated factors 
in preterm infants, yet there is an increasing need to better understand the reasons for vaccine 
hesitancy across the population (WHO, 2017), and the scope of this review means that this has 
not be addressed.   
CONCLUSION 
This integrative review aimed to answer the questions: (1) is there a delay in the vaccination 
of preterm infants?, and (2) what are the factors associated with vaccination timeliness in 
preterm infants? The process of narrative synthesis guided the analysis of the studies included 
and the following conclusions can be drawn: firstly, the studies used a variety of methods to 
investigate the topic but overall, they support the notion that vaccinations are delayed in 
preterm infants. Low birth weight is a strong indicator of a delay and given that prematurity is 
a leading cause of low birth weight, gestational age as an indicator must also be acknowledged. 
Certain family characteristics were associated with a delay, more specifically, the level of 
parental education and income. In accordance with previous population based enquiries, some 
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studies found that a lower level of education and income meant that a delay was more probable 
in preterm infants. Others found the opposite, and postulated that this was more than likely due 
to the increased amount of follow up support visits these families receive. The findings of the 
review suggest that increased follow up, targeted education and information, and better 
discharge planning may be strategies employed to increase vaccination uptake and rates in 
preterm infants.  
The findings of this review have both clinical and public health importance. Vaccination is a 
fundamental public health activity primarily undertaken in the community where nurses enact 
policies aimed at populations of unspecified individuals (Verweij & Dawson, 2007); equally, 
the decision to vaccinate a preterm infant in the acute care setting is likely to be based on 
clinical judgement centred on individual infants. Therefore it is vital that vaccination rates in 
this population along with an understanding of the barriers and facilitators are fully understood 
so that nurses and parents alike are supported in making informed decisions which are in the 
interests of those in their care. 
 
 
RELEVANCE TO CLINICAL PRACTICE 
Care providers need to be aware that preterm infants face an increased risk of a delay in being 
vaccinated. Therefore, health promotion strategies concerning vaccination should ensure 
inclusion of this population. Inappropriate delays in vaccinating preterm infants should be 
avoided by attendance at regular vaccination training and education events. Finally, thorough 
discharge planning for preterm infants must ensure a seamless transfer between services to 
avoid the risk of any vaccination delays. 
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Table 1. Summary of studies included in the review. 
Author, 
year, 
country 
Title of Study Study design Main outcomes Sample size Limitations 
Batra et al. 
(2009) 
US 
Evaluation of 
Vaccine Coverage 
for Low Birth 
Weight Infants 
During the First 
Year of Life in a 
Large Managed 
Care Population. 
Retrospective 
cohort analysis. 
Age specific up to date and 
age appropriate 
immunisation rates by birth 
weight in first year of life. 
ELBW n=506, 
VLBW n=788,  
LBW n=6491, 
NBW n=120,048 
Potential misclassification of 
data from existing database used 
in study. 
Crawford et 
al. (2009) 
Australia 
Immunisation 
practice in infants 
born prematurely: 
Neonatologists’ 
survey and 
clinical audit.  
Retrospective 
audit. 
Up to date immunisation 
status at 2, 4, 6, 12 and 18 
months. 
100 preterm infants No evidence of questionnaire 
testing for validity or reliability. 
Davis et al. 
(1999) 
US 
Immunization 
Levels Among 
Premature and 
Low-Birth-
Weight Infants 
and Risk Factors 
for Delayed Up-
to-Date 
Immunization 
status. 
Cohort & 
case/control 
analyses. 
Age specific immunisation 
status by prematurity and 
birth weight, and 
characteristics associated 
with timeliness.  
LBW n=11,580 
NBW n=173,373 
Unclear how ‘up-to-date’ 
vaccination status is defined. 
Denziot et al. 
(2011) 
France 
Hospital initiation 
of a vaccinal 
schedule 
Secondary data 
analysis and 
survey. 
Up to date immunisation 
status at 5 and 24 months. 
602 preterm infants Unable to determine quality of 
data from database used and lack 
improves the 
long-term 
vaccinal coverage 
of ex-pre-term 
children. 
of clarity regarding how the 
survey was developed. 
Langkamp et 
al. (2001) 
US 
Delays in Receipt 
of Immunizations 
in Low-Birth-
Weight Children. 
Logistic 
regression 
analysis 
Age at receipt of first 4 
doses of DTP vaccines, first 
3 polio vaccines and first 
MMR vaccine for MLBW, 
VLBW and NBW infants.   
Up to date status also 
examined at 12, 24 and 36 
months for infants in all 
weight categories. 
VLBW n= 447 
MLBW n= 648 
NBW n= 7,190 
Lack of more contemporary 
data. 
Magoon et al. 
(1995) 
US 
Delays in 
Immunizations of 
High-Risk Infants 
During the First 
Two Years of 
Life: Special Care 
for the High-Risk 
Infant Should Not 
Mean Special 
Immunization 
Schedules. 
Survey  Immunisation delays of 
more than 2 weeks in high 
risk infants, significant 
predictors of delays and 
practices among primary 
care providers. 
153 preterm infants Questionnaire used not tested for 
validity and reliability. 
McKechnie 
and Finlay 
(1999) 
UK 
Uptake and 
timing of 
immunisations in 
preterm and term 
infants. 
Retrospective 
secondary data 
analysis 
Mean vaccination age for 
preterm and full term infants 
at primary schedule (2, 3, 
and 4 months). 
110 preterm infants 
220 full term 
infants 
The 220 controls used were term 
infants also admitted to the unit, 
but the ‘normal’ health status of 
these infants cannot be 
confirmed so their value as a 
control could be compromised. 
Roper and 
Day (1988) 
UK 
Uptake of 
immunisations in 
low birthweight 
infants. 
Retrospective 
secondary data 
analysis 
Percentage uptake of first 
and third doses of primary 
immunisations by 
gestational age and birth 
weight.  
LBW n= 395 
NBW n= 3426 
Authors acknowledge there were 
some missing data. 
Ruiz et al. 
(1991) 
US 
Pertussis 
Immunization 
Patterns in 
Special Care 
Nursery 
Graduates. 
Survey Complete versus incomplete 
immunisation status in high 
risk and low risk infants at 1 
year of age. 
38 ‘high risk’ 
infants (includes 
infants with BW 
≤1500g) 
89 ‘low/normal 
risk’ infants 
Small sample and poor survey 
response rate, especially in the 
high risk group. 
 
Slack and 
Thwaites 
(2000) 
UK 
Timing of 
immunisation of 
premature infants 
on the neonatal 
unit and after 
discharge to the 
community. 
Retrospective 
case/control 
study 
Median age at first and third 
doses of primary schedule 
by gestational age and birth 
weight. 
212 preterm infants 
153 controls 
Completeness and accuracy of 
secondary data sources cannot 
be determined. 
Tillmann et 
al.  (2001) 
Switzerland 
Vaccination rate 
and age of 
premature infants 
weighing <1500 
g: a pilot study in 
north-western 
Switzerland. 
Retrospective 
case/control 
study 
Age in days of first 4 
scheduled doses of DTP, 
Polio, Hib and first MMR in 
preterm and full term 
infants. 
60 preterm infants 
60 full term infants 
No information regarding the 
development of the 
questionnaire. 
 
Tozzi et al. 
(2014) 
Italy 
Timeliness of 
routine 
immunization in a 
population-based 
Italian cohort of 
very preterm 
infants: Results of 
Prospective 
cohort study 
Proportion of children who 
had received at least 1 dose 
of HEXA, Pnc, MenC, 
MMR and Var at 24 months 
of age. 
1102 preterm 
infants 
Much of the follow up data 
relied on parental recall and 
compliance. 
the ACTION 
follow-up project. 
Wilson et al. 
(2012) 
Canada 
On-time 
Vaccination 
Coverage in 
Premature Infants 
in Ontario, 2002-
2009. 
Secondary data 
analysis 
Proportion of children (by 
gestational age) who had 
received at least 1 
vaccination during the 2, 4 , 
and 6 month visits within 
recommended time frame. 
65,687 preterm 
infants 
782,917 full term 
infants 
Original purpose of the database 
from which the study data were 
extracted is unclear. 
Woestenberg 
et al. (2014) 
Netherlands 
Delayed Start of 
Diphtheria, 
Tetanus, 
Acellular 
Pertussis and 
Inactivated Polio 
Vaccination in 
Preterm and Low 
Birth Weight 
Infants in the 
Netherlands. 
Secondary data 
analysis 
Individual age at first 
scheduled vaccination visit 
and median age at 5th and 
95th percentiles by 
gestational age and birth 
weight. 
60,835 preterm 
infants 
822,912 full term 
infants 
Researchers were restricted by 
the amount of variables to study. 
 
Table 2. Appraisal framework. 
Elements influencing the credibility of the study 
Study details  
Author(s)  
Source  
Writing style  
Report title  
Abstract  
Elements influencing the robustness of the research 
Purpose/research problem  
Logical consistency  
Literature review  
Theoretical framework  
Aims/objectives/research question/hypotheses  
Sample  
Ethical considerations  
Operational definitions  
Methodology 
• Design 
 
Is secondary data used? If yes then consider: 
• Is there sufficient data? 
• What was the original purpose for 
which the data were collected? 
• When and how were they collected? 
• Are the variables of interest included in 
the dataset? 
• What is the level of data aggregation? 
• What data cleaning procedures have 
been applied? 
• What sampling procedures were used? 
 
Data analysis/results 
• Results expressed in terms of 
prematurity, birth weight or both? 
• Degree of prematurity and/or birth eight 
classified? 
• Results expressed as infants being up to 
date (rates) or vaccinated on time (age 
appropriate vaccination)? 
• Are predictors in rates or delay 
explored? 
 
Discussion  
References  
